{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:13:41Z","timestamp":1783469621166,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004044.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000}}],"reference-count":87,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004044.pub5","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T17:18:56Z","timestamp":1638897536000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Pharmacological treatment for psychotic depression"],"prefix":"10.1002","volume":"2021","author":[{"given":"Jacolien","family":"Kruizinga","sequence":"additional","affiliation":[{"name":"PsyQ Emmen; Emmen Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Liemburg","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences; University of Groningen; Groningen Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huibert","family":"Burger","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University Medical Center Groningen, University of Groningen; Groningen Netherlands"},{"name":"Department of Epidemiology; University Medical Center Groningen, University of Groningen; Groningen Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cipriani","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Geddes","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Robertson","sequence":"additional","affiliation":[{"name":"Cochrane Common Mental Disorders; University of York; York UK"},{"name":"Centre for Reviews and Dissemination; University of York; York UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrix","family":"Vogelaar","sequence":"additional","affiliation":[{"name":"Trimbos Institute; Utrecht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A","family":"Nolen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University Medical Center Groningen, University of Groningen; Groningen Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD004044.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1176\/ajp.147.9.1203","article-title":"Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression","volume":"147","year":"1990","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004044.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-0327(93)90041-H","article-title":"Response of psychotic depression subtypes to pharmacotherapy","volume":"28","year":"1993","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1002\/14651858.CD004044.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02246131","article-title":"A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients","volume":"127","author":"Bruijn","year":"1996","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD004044.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-2007-979200","article-title":"Depressed in-patients respond differently to imipramine and mirtazapine","volume":"32","author":"Bruijn","year":"1999","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0005|cit5","doi-asserted-by":"crossref","unstructured":"Andreescu C Mulsant BH Peasley-Miklus C Rothschild AJ Flint AJ Heo M Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features Journal of Clinical Psychiatry 2007 68 2 194 200","DOI":"10.4088\/JCP.v68n0203"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0006|cit6","doi-asserted-by":"crossref","unstructured":"Blumberger DM Mulsant BH Emeremni C Houck P Andreescu C Mazumdar S Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial Journal of Psychiatric Research 2011 45 7 896 901","DOI":"10.1016\/j.jpsychires.2011.01.003"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0007|cit7","article-title":"Challenges in conducting a pharmacotherapy study in psychotic depression","author":"Flint","journal-title":"157th Annual Meeting of the American Psychiatric Association; 2004 May 1-6; New York, NY. No. 63D"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0008|cit8","unstructured":"Meyers B Rothschild A Gabriele M English J McShea M Kamara T Effectiveness of selective serotonin reuptake inhibitors combined with antipsychotic medication for the treatment of psychotic depression [STOP-PD; NCT00056472] ClinicalTrials.gov [http:\/\/www.clinicaltrials.gov] 2004"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0009|cit9","doi-asserted-by":"crossref","unstructured":"Meyers BS Flint AJ Rothschild AJ Mulsant BH Whyte EM Peasley-Miklus C A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD) Archives of General Psychiatry 2009 66 8 838 47","DOI":"10.1001\/archgenpsychiatry.2009.79"},{"issue":"6","key":"10.1002\/14651858.CD004044.pub5-BIB0010|cit10","first-page":"625","article-title":"Errors in table in: a double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD)","volume":"68","author":"Meyers","year":"2011","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0011|cit11","article-title":"Diagnosis and treatment of psychosis in geriatric major depression","author":"Meyers","journal-title":"46th Annual NCDEU (New Clinical Drug Evaluation Unit) Meeting; 2006 June 12-15; Boca Raton, FL. p 83"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1521\/suli.2008.38.4.403","article-title":"Correlates of suicidality among patients with psychotic depression","volume":"38","author":"Schaffer","year":"2008","journal-title":"Suicide and Life-Threatening Behavior"},{"issue":"3","key":"10.1002\/14651858.CD004044.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.psychres.2012.02.015","article-title":"Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression","volume":"197","author":"Weissman","year":"2012","journal-title":"Psychiatry Research"},{"issue":"8","key":"10.1002\/14651858.CD004044.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4088\/JCP.v62n0804","article-title":"A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life","volume":"62","author":"Mulsant","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0015|cit15","doi-asserted-by":"crossref","unstructured":"Rothschild AJ Williamson DJ Tohen MF Schatzberg A Andersen SW Van Campen LE A double-blind, randomized study of olanzapine and olanzapine\/fluoxetine combination for major depression with psychotic features Journal of Clinical Psychopharmacology 2004 24 4 365 73","DOI":"10.1097\/01.jcp.0000130557.08996.7a"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0016|cit16","first-page":"NR549","article-title":"Olanzapine-fluoxetine combination for difficult-to-treat depression","author":"Williamson","journal-title":"154th Annual Meeting of the American Psychiatric Association; 2001 May 5-10; New Orleans; LA"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub5-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/01.jcp.0000130557.08996.7a","article-title":"A double-blind, randomized study of olanzapine and olanzapine\/fluoxetine combination for major depression with psychotic features","volume":"24","author":"Rothschild","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0018|cit18","first-page":"NR549","article-title":"Olanzapine-fluoxetine combination for difficult-to-treat depression","author":"Williamson","journal-title":"154th Annual Meeting of the American Psychiatric Association; 2001 May 5-10; New Orleans; LA"},{"issue":"6","key":"10.1002\/14651858.CD004044.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00004714-198612000-00003","article-title":"The pharmacological treatment of delusional depression: part II","volume":"6","author":"Spiker","year":"1986","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub5-BIB0020|cit20","first-page":"184","article-title":"Pharmacological treatment of delusional depressives","volume":"18","author":"Spiker","year":"1982","journal-title":"Psychopharmacology Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1176\/ajp.142.4.430","article-title":"The pharmacological treatment of delusional depression","volume":"142","author":"Spiker","year":"1985","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004044.pub5-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0165-0327(88)90067-5","article-title":"Placebo response rates in psychotic and nonpsychotic depression","volume":"14","author":"Spiker","year":"1988","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0023|cit23","doi-asserted-by":"crossref","unstructured":"van den Broek WW Birkenh\u00e4ger TK Mulder PG Bruijn J Moleman P A double blind study comparing imipramine with fluvoxamine in depressed inpatients Psychopharmacology 2004 175 4 481 6","DOI":"10.1007\/s00213-004-1853-3"},{"issue":"3","key":"10.1002\/14651858.CD004044.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1600-0447.2009.01464.x","article-title":"Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine","volume":"121","author":"Wijkstra","year":"2010","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"12","key":"10.1002\/14651858.CD004044.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1176\/ajp.153.12.1631","article-title":"Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression","volume":"153","author":"Zanardi","year":"1996","journal-title":"American Journal of Psychiatry."},{"issue":"1","key":"10.1002\/14651858.CD004044.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4088\/JCP.v61n0107","article-title":"Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study","volume":"61","author":"Zanardi","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004044.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00004714-200110000-00009","article-title":"Rapid reversal of psychotic depression using mifepristone","volume":"21","author":"Belanoff","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0028|cit28","first-page":"32","article-title":"A double blind study with fluvoxamine vs. desipramine combined with placebo or haloperidol in delusional depression","volume":"9","author":"Bellini","year":"1994","journal-title":"Critical Issues in the Treatment of Affective Disorders"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cct.2009.03.001","article-title":"A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction","volume":"30","author":"Blasey","year":"2009","journal-title":"Contemporary Clinical Trials"},{"issue":"5","key":"10.1002\/14651858.CD004044.pub5-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cct.2009.06.010","article-title":"Corrigendum to 'A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction' [Contemp. Clin. Trials 30 (2009)284-288]","volume":"30","author":"Blasey","year":"2009","journal-title":"Contemporary Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD004044.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cct.2009.10.001","article-title":"Corrigendum to 'A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction' [Contemp. Clin. Trials 30 (2009) 284-288]","volume":"31","author":"Blasey","year":"2010","journal-title":"Contemporary Clinical Trials"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub5-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/JCP.0b013e3182239191","article-title":"Efficacy and safety of mifepristone for the treatment of psychotic depression","volume":"31","author":"Block","year":"2011","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD004044.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/JCP.0000000000000744","article-title":"Mifepristone plasma level and glucocorticoid receptor antagonism associated with response in patients with psychotic depression","volume":"37","author":"Block","year":"2017","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004044.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biopsych.2018.01.008","article-title":"Combined analysis of mifepristone for psychotic depression: plasma levels associated with clinical response","volume":"84","author":"Block","year":"2018","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/s-2007-1017421","article-title":"A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitor","volume":"17","author":"Casacchia","year":"1984","journal-title":"Pharmacopsychiatry"},{"issue":"10","key":"10.1002\/14651858.CD004044.pub5-BIB0036|cit36","first-page":"395","article-title":"A comparison of phenelzine and imipramine in depressed inpatients","volume":"42","author":"Davidson","year":"1981","journal-title":"Journal of Clinical Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD004044.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.biopsych.2006.05.034","article-title":"Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression","volume":"15","author":"DeBattista","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004044.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004714-199704000-00018","article-title":"Lithium-TCA combination treatment of psychotic depression: comparison with TCA-neuroleptic treatment","volume":"17","author":"Ebert","year":"1997","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD004044.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.npp.1300884","article-title":"Clinical and biological effects of mifepristone treatment for psychotic depression","volume":"31","author":"Flores","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004044.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0022-3956(66)90012-4","article-title":"Imipramine (tofranil vs. placebo in hospitalized psychotic depressives (a comparison of patients' self-ratings, psychiatrists' ratings and psychological test scores)","volume":"4","author":"Friedman","year":"1966","journal-title":"Journal of Psychiatric Research"},{"issue":"7","key":"10.1002\/14651858.CD004044.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jpsychires.2008.10.004","article-title":"Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol - a double-blind multicenter trial","volume":"43","author":"K\u00fcnzel","year":"2009","journal-title":"Journal of Psychiatric Research"},{"issue":"5","key":"10.1002\/14651858.CD004044.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00004714-199910000-00011","article-title":"Limited efficacy of ketoconazole in treatment-refractory major depression","volume":"19","author":"Malison","year":"1999","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD004044.pub5-BIB0043|cit43","first-page":"85","article-title":"Therapy for psychotic and psychoneurotic depression with thiothixene and perphenazine-amitriptyline (a double-blind clinical study)","volume":"30","author":"McLaughlin","year":"1969","journal-title":"Diseases of the Nervous System"},{"issue":"2","key":"10.1002\/14651858.CD004044.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004714-199804000-00003","article-title":"Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome","volume":"18","author":"Muller-Siecheneder","year":"1998","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD004044.pub5-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1034\/j.1600-0447.2001.00228.x","article-title":"Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study","volume":"103","author":"Navarro","year":"2001","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3-4","key":"10.1002\/14651858.CD004044.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0165-0327(84)80008-7","article-title":"Phenomenology, neuroendocrine function, and tricyclic antidepressant response","volume":"6","author":"Nelson","year":"1984","journal-title":"Journal of Affective Disorders"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub5-BIB0047|cit47","first-page":"184","article-title":"Pharmacological treatment of delusional depressives","volume":"18","author":"Spiker","year":"1982","journal-title":"Psychopharmacology Bulletin"},{"issue":"6","key":"10.1002\/14651858.CD004044.pub5-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00004714-199812000-00004","article-title":"Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study","volume":"18","author":"Zanardi","year":"1998","journal-title":"Journal of Clinical Psychopharmacology."},{"key":"10.1002\/14651858.CD004044.pub5-BIB0049|cit49","volume-title":"Cochrane Reviewer's Handbook 4.2.2","author":"Alderson","year":"2004"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0050|cit50","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III)","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0051|cit51","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R)","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0052|cit52","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0053|cit53","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0054|cit54","volume-title":"Practice Guideline for the Treatment of Patients With Major Depressive Disorder (revision)","author":"American Psychiatric Association","year":"2010"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0055|cit55","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-V)","author":"American Psychiatric Association","year":"2013"},{"issue":"9","key":"10.1002\/14651858.CD004044.pub5-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00005053-198409000-00002","article-title":"The clinical and neuroendocrine features of psychotic depression","volume":"172","author":"Coryell","year":"1984","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0057|cit57","first-page":"22","article-title":"The treatment of psychotic depression","volume":"59(Suppl 1)","author":"Coryell","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD004044.pub5-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.psyneuen.2006.04.003","article-title":"Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates","volume":"31","author":"Duval","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4088\/JCP.11r07324","article-title":"Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment","volume":"73","author":"Farahani","year":"2012","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0060|cit60","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) (accessed prior to 3 March 2020)"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0061|cit61","doi-asserted-by":"crossref","unstructured":"Guy W Clinical Global Impression. ECDEU Assessment Manual for Psychopharmacology, revised Rockville, MD: National Institute of Mental Health, 1976","DOI":"10.1037\/e591322011-001"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurological and Neurosurgical Psychiatry"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0063|cit63","unstructured":"Higgins JT Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0064|cit64","unstructured":"Higgins JT Savovi\u0107 J Page MJ Elbers RG Sterne JAC Chapter 8. Assessing risk of bias in a randomized trial. In: Higgins JT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from www.training.cochrane.org\/handbook"},{"issue":"12","key":"10.1002\/14651858.CD004044.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archpsyc.1991.01810360039006","article-title":"The validity of major depression with psychotic features based on a community study","volume":"48","author":"Johnson","year":"1991","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004044.pub5-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.biopsych.2005.10.014","article-title":"Cortisol\u00a0circadian rhythm alterations in psychotic major depression","volume":"60","author":"Keller","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004044.pub5-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0447.2008.01237.x","article-title":"Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration","volume":"118","author":"Licht","year":"2008","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0447.2009.01382.x","article-title":"Clinical practice recommendations for depression","volume":"119","author":"Mahli","year":"2009","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0070|cit70","unstructured":"Spijker J Bockting CLH Meeuwissen JAC Emmelkamp PMG Hermens MLM Multidisciplinaire richtlijn Depressie (Derde revisie). Richtlijn voor de diagnostiek, behandeling en begeleiding van volwassen pati\u00ebnten met een depressieve stoornis; 2013. Utrecht: Trimbos Institute Available at www.nvvp.net\/stream\/richtlijn-depressie-2013.pdf"},{"issue":"11","key":"10.1002\/14651858.CD004044.pub5-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1176\/ajp.154.11.1497","article-title":"DST studies in psychotic depression: a meta-analysis","volume":"154","author":"Nelson","year":"1997","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0072|cit72","volume-title":"The treatment and management of depression in adults (updated version). National Clinical Practice Guideline 90","author":"National Institute for Health and Clinical Excellence","year":"2009"},{"issue":"11","key":"10.1002\/14651858.CD004044.pub5-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1176\/appi.ajp.159.11.1855","article-title":"Prevalence of depressive episodes with psychotic features in the general population","volume":"159","author":"Ohayon","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004044.pub5-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-0327(92)90056-C","article-title":"Psychotic (delusional) depression: a meta-analysis of physical treatments","volume":"24","author":"Parker","year":"1992","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1002\/14651858.CD004044.pub5-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0165-1781(90)90098-P","article-title":"Medication resistance and clinical response to electroconvulsive therapy","volume":"31","author":"Prudic","year":"1990","journal-title":"Psychiatry Research"},{"issue":"8","key":"10.1002\/14651858.CD004044.pub5-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1176\/ajp.153.8.985","article-title":"Resistance to antidepressant medications and short-term clinical response to ECT","volume":"153","author":"Prudic","year":"1996","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0077|cit77","unstructured":"Review Manager 5 (RevMan) The Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0078|cit78","first-page":"10","article-title":"The definition and meaning of treatment-resistant depression","volume":"62(Suppl 16)","author":"Sackeim","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0079|cit79","volume-title":"Comrehensive Textbook of Psychiatry","author":"Sadock","year":"2009"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0080|cit80","unstructured":"Sch\u00fcnemann HJ Higgins JT Vist GE Glasziou P Akl EA Skoetz N Chapter 14. Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JT, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, et al, editor(s), Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated September 2020). Cochrane, 2020 Available from www.training.cochrane.org\/handbook"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub5-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/01.jcp.0000130551.70878.56","article-title":"Effect of antidepressant medication resistance on short-term response to ECT","volume":"24","author":"den Broek","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD004044.pub5-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00004714-200010000-00003","article-title":"Somatic treatment of psychotic depression: review and recommendations for practice","volume":"20","author":"Wheeler Vega","year":"2000","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004044.pub5-BIB0083|cit83","first-page":"1","article-title":"Treatment of unipolar psychotic depression: the use of evidence in practice guideline","volume":"24","author":"Wijkstra","year":"2007","journal-title":"World Journal of Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004044.pub5-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004044","article-title":"Pharmacological treatment for psychotic depression","author":"Wijkstra","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004044.pub5-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004044.pub2","article-title":"Pharmacological treatment for psychotic depression","author":"Wijkstra","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD004044.pub5-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004044.pub3","article-title":"Pharmacological treatment for psychotic depression","author":"Wijkstra","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD004044.pub5-BIB0087|cit87","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004044.pub4","article-title":"Pharmacological treatment for psychotic depression","author":"Wijkstra","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:06:02Z","timestamp":1751241962000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004044.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":87,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004044.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,7]]}}}